Posts
What breaks first if the 10-year stays this high: AI valuations or AI capex?
I've been thinking about these as two separate questions that often get lumped together. **1. Does AI spending continue?** Probably a question of competitive necessity, demand and access to capital. **2. What are those future cash flows worth to shareholders?** That's where the discount rate matters regardless of how important …
PANW: AI May Make Cybersecurity More Essential, Not Less
# PANW: AI May Make Cybersecurity More Essential, Not Less **Palo Alto Networks (PANW) trades around $390.** The company is increasingly moving beyond its firewall roots toward a broad enterprise security platform spanning Network & AI Security, Cortex, Cloud and Identity. FY2026 revenue reached **$11.48B, up 24.5%**, while Q4 revenue …
GEV: AI Needs More Than Chips — It Needs Power
# GEV: AI Needs More Than Chips — It Needs Power **GE Vernova (GEV) trades around $955.** GEV is increasingly becoming a direct beneficiary of the multi-year power infrastructure buildout driven by AI data centers, grid modernization and global electricity shortages. In Q2 2026, orders reached **$24.2B, up 88% organically**, …
Which stocks are you holding for the next 20 years? (Plus: eyeing Teradata)
Been digging into the AI infrastructure + semi stack after seeing a few threads on long-duration AI bets. Here’s every ticker I’ve seen floated so far in these discussions (cleaned up and de-duplicated): **AI / Data-center infra** * NBIS – Nebius Group * APLD – Applied Digital * KEEL – …
I'm new and my investment (META) is at ATH, what to do?
Yep, I'm new, invested around €1000 euros (2 shares) at August 31, was €480 or so. Now it's €678. Honestly, I have no clue. Muse was released and the rip on the stock seems justified, but I absolutely have no idea for how long can I milk this cow. My …
GIII: three retailers are ~40% of sales. Ross dipped to 11.0% in FY26 after jumping to 12.6%
Went through G-III Apparel's last three 10-Ks for the customer concentration disclosure: * Macy's: 19.2% → 18.0% → 20.6% * TJX: 13.6% → 13.2% → 11.4% * Ross: 10.1% → 12.6% → 11.0% * Top 10 customers: 70.1% → 69.6% → 67.6% (FY24 → FY25 → FY26; fiscal years end …
Boston Scientific $BSX - A Life-Saving Medical Devices Champion
BSX is one of the largest medical-device companies in the world, focused mainly on cardiovascular, endoscopy, urology and neuromodulation. Think catheters, ablation systems, stents, implantable devices and other products used during minimally invasive procedures The stock is around $45 as of September 24, 2026, with a market capitalization of roughly …
Give a stock and Ill provide some insights
Hey all — I've been building a research tool that pulls a stock's fundamentals and runs it through a handful of value-investing models: Piotroski F-Score, Altman Z-Score, NCAV, DCF, EPV, Magic Formula, DuPont, and a composite "Explainable Score" that shows exactly which signals drove the grade — no black box, …
Nike- NKE- The Shoe Jester that was king becomes a dog
What do you think of the 8-10% chance priced into the options market that Nke stock would decrease further from its 12-year low of 35.6 to rest at a stock price of 15 dollars or less? I think it would be a value stock if it reaches a 92+% drawdown …
RCL at ~$230: Sandals widens the moat, but I don’t think the deal is cheap
RCL is around $230. Its 2026 adjusted EPS guide is $17.73-$17.87, and capacity is set to grow 4%, 6% and 7% in 2027-29. Now it is paying $3B for 50% of Sandals and Beaches at about 10x forward EBITDA. That implies roughly $300M of EBITDA for RCL’s share. The whole …